Oxybutynin Chloride - NDC Database (Page 11)
72789-049 Dec 20, 2016
Oxybutynin Chloride 10 mg Oral Tablet, Extended Release by Pd-rx Pharmaceuticals, Inc.
Oxybutynin Chloride 10 mg Oral Tablet, Extended Release by Pd-rx Pharmaceuticals, Inc.
72888-030 Oct 27, 2020
Oxybutynin Chloride 5 mg Oral Tablet, Extended Release by Advagen Pharma Limited
Oxybutynin Chloride 5 mg Oral Tablet, Extended Release by Advagen Pharma Limited
72888-031 Oct 27, 2020
Oxybutynin Chloride 10 mg Oral Tablet, Extended Release by Advagen Pharma Limited
Oxybutynin Chloride 10 mg Oral Tablet, Extended Release by Advagen Pharma Limited
72888-032 Oct 27, 2020
Oxybutynin Chloride 15 mg Oral Tablet, Extended Release by Advagen Pharma Limited
Oxybutynin Chloride 15 mg Oral Tablet, Extended Release by Advagen Pharma Limited
Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.